Company Filing History:
Years Active: 2013-2020
Title: The Innovations of Andrew Tarling
Introduction
Andrew Tarling is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceutical compositions and methods for inhibiting mammalian alpha-amylase. With a total of 2 patents, his work focuses on addressing various health conditions related to glycemic control and gastrointestinal disorders.
Latest Patents
One of Andrew Tarling's latest patents is titled "Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compositions thereof." This patent provides methods, uses, and pharmaceutical compositions for the inhibition of mammalian alpha-amylase in subjects. The invention is particularly beneficial for individuals at risk of developing conditions such as Middleton syndrome, diabetes mellitus, obesity, and other related disorders.
Another significant patent is "Alpha-amylase inhibitors: the montbretins and uses thereof." This patent highlights naturally occurring glycosylated acyl-flavonols that effectively inhibit mammalian alpha-amylase. These compounds, derived from specific plants, are useful in managing starch digestion, glycemia in diabetic subjects, and controlling oral health issues like plaque formation.
Career Highlights
Andrew Tarling is affiliated with the University of British Columbia, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on public health and the management of chronic conditions.
Collaborations
Throughout his career, Andrew has collaborated with esteemed colleagues such as Stephen G. Withers and Raymond John Andersen. These partnerships have contributed to the development of his innovative patents and research initiatives.
Conclusion
Andrew Tarling's contributions to the field of pharmaceutical sciences demonstrate his commitment to improving health outcomes through innovative solutions. His patents reflect a deep understanding of the complexities of glycemic control and gastrointestinal health.